IP Protection Support Strong in the Congress

IP Protection Support Strong in the Congress

03.26.13 | By Mark Grayson

Last week Senate Finance Committee Chair, Max Baucus (D. MT), and Ranking Member Orrin Hatch (R. UT) took a strong stand urging that the Administration secure robust intellectual property (IP) standards in the Trans-Pacific Partnership (TPP). In a letter to Ambassador Demetrios Marantis, Acting U.S. Trade Representative, the Senators said, "We urge you to seek commitments from our trading partners that reflect the level of protection under U.S. law, for example, 12 years of regulatory data protection for biologic pharmaceuticals and strong remedies, including civil and criminal penalties, for trade secret theft."

The Senators state that, "Intellectual property is the lifeblood of the U.S. economy, and the protection of intellectual property is essential to U.S. jobs and competitiveness."

We strongly agree. We need our negotiators to ensure that TPP is a 21st century agreement that recognizes that the protection of intellectual property is imperative for the world's knowledge based economies. Moreover, in the case of biopharmaceuticals, strong IP protections are critical to ensuring that the next generation of medicines are developed and reach the patients across the globe. In fact, U.S. biopharmaceutical companies are currently developing 907 biologics targeting more than 100 diseases.


Hide Comments

More On PhRMA — powered by PhRMApedia


Cost in Context